cnbc.com/2024/04/04/drug-si...
And they are no longer manufacturing this older drug as it would be a "cheap" drug. It will be repurposed and cost $$$. I know I am being cynical.
Sanofi pulled lixisenatide from the market at the beginning of 2023. The French drugmaker has said the discontinuation of the treatment was a business decision that was unrelated to its safety and efficacy.
Sanofi provided the drug to the researchers and advised them on the characteristics of the medication, but otherwise was not involved in the new phase two trial, which was funded by the French Ministry for Health and Prevention and a U.K. charity called Cure Parkinson’s.
-Syd